Major Depressive Disorder Study In Adults

Completed · Phase 4

Conditions studied: Major Depressive Disorder

In brief

A study to obtain safety and tolerability data

Key facts

Study ID

NCT00049972

Run by

GlaxoSmithKline

People needed

646

Starts

2002-09-01

Expected to finish

2003-09-01

Last updated by the study team

2017-09-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient must have primary diagnosis of Major Depressive Disorder (MDD).
• Discontinued a selective serotonin reuptake inhibitor (SSRI)or serotonin-norepinephrine reuptake inhibitor (SNRI) regimen due to intolerability.
• Minimum time frame between last dose of previous antidepressant and initiation of study drug is one week.
• Maximum time frame between last dose of prior antidepressant and initiation of study drug is 2 months.

You may not qualify if…

• Patient has previously been treated with the study drug.
• Is experiencing an adverse event attributed to previous SSRI/SNRI use that has not been resolved at least one week prior to Baseline Visit.
• Has a history of seizure disorder.
• Has met criteria for substance abuse or dependence within 6 months prior to Baseline Visit.
• Currently using an antidepressant.
• Currently pregnant.

Where it is running

• GSK Clinical Trial Call Center — Birmingham, Alabama, United States
• GSK Clinical Trial Call Center — Fairfield, Alabama, United States
• GSK Clinical Trial Call Center — Mobile, Alabama, United States
• GSK Clinical Trial Call Center — Phoenix, Arizona, United States
• GSK Clinical Trial Call Center — Little Rock, Arkansas, United States
• GSK Clinical Trial Call Center — Little Rock, Arkansas, United States
• GSK Clinical Trial Call Center — Anaheim, California, United States
• GSK Clinical Trial Call Center — Anaheim Hills, California, United States
• GSK Clinical Trial Call Center — Bellflower, California, United States
• GSK Clinical Trial Call Center — Cerritos, California, United States
• GSK Clinical Trial Call Center — Clovis, California, United States
• GSK Clinical Trial Call Center — Encino, California, United States
• GSK Clinical Trial Call Center — Petaluma, California, United States
• GSK Clinical Trial Call Center — Riverside, California, United States
• GSK Clinical Trial Call Center — Sacramento, California, United States
• GSK Clinical Trial Call Center — Sacramento, California, United States
• GSK Clinical Trial Call Center — San Francisco, California, United States
• GSK Clinical Trial Call Center — Temecula, California, United States
• GSK Clinical Trial Call Center — Vista, California, United States
• GSK Clinical Trial Call Center — Colorado Springs, Colorado, United States
• GSK Clinical Trial Call Center — Wilmington, Delaware, United States
• GSK Clinical Trial Call Center — Wilmington, Delaware, United States
• GSK Clinical Trial Call Center — Boynton Beach, Florida, United States
• GSK Clinical Trial Call Center — Delray Beach, Florida, United States
• GSK Clinical Trial Call Center — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.